Sandra Cuellar‐Baena

Sandra Cuellar‐Baena

Auto-generated profile, based on publicly available information

Sandra Cuellar‐Baena

Departments of Clinical Sciences/Division of Radiology

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Tomography
Verified
Journal Article
Open access
FDFaris Durmo
Faris Durmo
ARAnna Rydelius
Anna Rydelius
SBSandra Cuellar Baena
Sandra Cuellar Baena
KAKrister Askaner
Krister Askaner
JLJimmy Lätt
Jimmy Lätt
PSPia C Sundgren
Pia C Sundgren
We investigated multivoxel proton magnetic resonance spectroscopy (1H-MRS) biometrics for preoperative differentiation and prognosis of patients with brain metastases (MET), low-grade glioma (LGG) and high-grade glioma (HGG). In total, 33 patients (HGG, 14; LGG, 9; and 10 MET) were included. 1H-MRS imaging (MRSI) data were assessed and neurochemical profiles for metabolites N-acetyl aspartate (NAA) + NAAG(NAA), Cr + PCr(total creatine, tCr), Glu + Gln(Glx), lactate (Lac), myo-inositol(Ins), GPC + PCho(total choline, tCho), and total lipids, and macromolecule (tMM) signals were estimated. Metabolites were reported as absolute concentrations or ratios to tCho or tCr levels. Voxels of interest in an MRSI matrix were labeled according to tissue. Logistic regression, receiver operating characteristic, and Kaplan–Meier survival analysis was performed. Across HGG, LGG, and MET, average Ins/tCho was shown to be prognostic for overall survival (OS): low values (≤1.29) in affected hemisphere predicting worse OS than high values (>1.29), (log rank < 0.007). Lip/tCho and Ins/tCho combined showed 100% sensitivity and specificity for both HGG/LGG (P < .001) and LGG/MET (P < .001) measured in nonenhancing/contrast-enhancing lesional tissue. Combining tCr/tCho in perilesional edema with tCho/tCr and NAA/tCho from ipsilateral normal- appearing tissue yielded 100% sensitivity and 81.8% specificity (P < .002) for HGG/MET. Best single biomarker: Ins/tCho for HGG/LGG and total lipid/tCho for LGG/MET showed 100% sensitivity and 75% and 100% specificity, respectively. HGG/MET; NAA/tCho showed 75% sensitivity and 84.6% specificity. Multivoxel 1H-MRSI provides prognostic information for OS for HGG/LGG/MET and a multibiometric approach for differentiation may equal or outperform single biometrics.

21 October 2010 in International Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
DMDaniel Monleon
Daniel Monleon
SCS. Cuellar-Baena
S. Cuellar-Baena
JMJ. M. Morales
J. M. Morales
HMH. Martinetto
H. Martinetto
JCJ. Calvar
J. Calvar
BCB. Celda
B. Celda
Brain tumours are the most common solid tumours in children and a major cause of childhood mortality. The most common paediatric brain tumours include ependymomas, cerebellar astrocytomas and medulloblastomas. These brain tumours are highly heterogeneous regarding their histology, prognosis and therapeutic response. Subtle biochemical changes can be detected in intact tissues by High-Resolution Proton Magnetic Angle Spinning Spectroscopy (HR-MAS) revealing the status of tumour microheterogeneity and metabolic alterations before they are morphologically detectable. In this study, we present metabolic profiles by HR-MAS of 20 intact tissue samples from paediatric brain tumours. Tumour types include ependymoma, medulloblastoma and pilocytic astrocytoma. The metabolic characterization of paediatric brain tumour tissue by HR-MAS spectroscopy provided differential patterns for these tumours. The metabolic composition of the tumour tissue was highly consistent with previous in vivo and ex vivo studies. Some resonances detected in this work and not previously observed by in vivo spectroscopy also show potential in determining tumour type and grade (fatty acids, phenylalanine, glutamate). Overall, this work suggests that the additional information obtained by NMR metabolic profiling applied to tissue from paediatric brain tumours may be useful for assessing tumour grade and determining optimum treatment strategies.

11 November 2011
Verified
Book Chapter
Closed access
PDF file
HHHélène Hall
Hélène Hall
SCSandra Cuellar-Baena
Sandra Cuellar-Baena
CDCarina Dahlberg
Carina Dahlberg
RZRene in 't Zandt
Rene in 't Zandt
VDVladimir Denisov
Vladimir Denisov
DKDeniz Kirik
Deniz Kirik

24 September 2012 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
HHHélène Hall
Hélène Hall
SCSandra Cuellar‐Baena
Sandra Cuellar‐Baena
VDVladimir Denisov
Vladimir Denisov
DKDeniz Kirik
Deniz Kirik
Choline acetyltransferase (ChAT) is the key enzyme for acetylcholine (ACh) synthesis and constitutes a reliable marker for the integrity of cholinergic neurons. Cortical ChAT activity is decreased in the brain of patients suffering from Alzheimer's and Parkinson's diseases. The standard method used to measure the activity of ChAT enzyme relies on a very sensitive radiometric assay, but can only be performed on post‐mortem tissue samples. Here, we demonstrate the possibility to monitor ACh synthesis in rat brain homogenates in real time using NMR spectroscopy. First, the experimental conditions of the radiometric assay were carefully adjusted to produce maximum ACh levels. This was important for translating the assay to NMR, which has a low intrinsic sensitivity. We then used 15N‐choline and a pulse sequence designed to filter proton polarization by nitrogen coupling before 1H‐NMR detection. ACh signal was resolved from choline signal and therefore it was possible to monitor ChAT‐mediated ACh synthesis selectively over time. We propose that the present approach using a labeled precursor to monitor the enzymatic synthesis of ACh in rat brain homogenates through real‐time NMR represents a useful tool to detect neurotransmitter synthesis. This method may be adapted to assess the state of the cholinergic system in the brain in vivo in a non‐invasive manner using NMR spectroscopic techniques.

1 April 2011 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
SCS. Cuellar-Baena
S. Cuellar-Baena
LML.M.T.S. Morais
L.M.T.S. Morais
FCFernando Cendes
Fernando Cendes
AFA.V. Faria
A.V. Faria
GCGabriela Castellano
Gabriela Castellano
In vivo proton magnetic resonance spectroscopy (H-1-MRS) is a technique capable of assessing biochemical content and pathways in normal and pathological tissue. In the brain, H-1-MRS complements the information given by magnetic resonance images. The main goal of the present study was to assess the accuracy of H-1-MRS for the classification of brain tumors in a pilot study comparing results obtained by manual and semi-automatic quantification of metabolites. In vivo single-voxel H-1-MRS was performed in 24 control subjects and 26 patients with brain neoplasms that included meningiomas, high-grade neuroglial tumors and pilocytic astrocytomas. Seven metabolite groups (lactate, lipids, N-acetyl-aspartate, glutamate and glutamine group, total creatine, total choline, myo-inositol) were evaluated in all spectra by two methods: a manual one consisting of integration of manually defined peak areas, and the advanced method for accurate, robust and efficient spectral fitting (AMARES), a semi-automatic quantification method implemented in the jMRUI software. Statistical methods included discriminant analysis and the leave-one-out cross-validation method. Both manual and semi-automatic analyses detected differences in metabolite content between tumor groups and controls (P < 0.005). The classification accuracy obtained with the manual method was 75% for high-grade neuroglial tumors, 55% for meningiomas and 56% for pilocytic astrocytomas, while for the semi-automatic method it was 78, 70, and 98%, respectively. Both methods classified all control subjects correctly. The study demonstrated that H-1-MRS accurately differentiated normal from tumoral brain tissue and confirmed the superiority of the semi-automatic quantification method.

17 February 2016 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
SCSandra Cuellar‐Baena
Sandra Cuellar‐Baena
NLNatalie Landeck
Natalie Landeck
SSSarah Sonnay
Sarah Sonnay
KBKerstin Buck
Kerstin Buck
Vladimir MlynarikVladimir Mlynarik
Vladimir Mlynarik
DKDeniz Kirik
Deniz Kirik